Free Trial

Syndax Pharmaceuticals (SNDX) Competitors

Syndax Pharmaceuticals logo
$15.01 +0.16 (+1.08%)
Closing price 04:00 PM Eastern
Extended Trading
$15.13 +0.12 (+0.80%)
As of 07:19 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

SNDX vs. TGTX, PTCT, KRYS, ACLX, ARWR, ACAD, MENS, PCVX, PTGX, and ADMA

Should you be buying Syndax Pharmaceuticals stock or one of its competitors? The main competitors of Syndax Pharmaceuticals include TG Therapeutics (TGTX), PTC Therapeutics (PTCT), Krystal Biotech (KRYS), Arcellx (ACLX), Arrowhead Pharmaceuticals (ARWR), ACADIA Pharmaceuticals (ACAD), Jyong Biotech (MENS), Vaxcyte (PCVX), Protagonist Therapeutics (PTGX), and ADMA Biologics (ADMA). These companies are all part of the "pharmaceutical products" industry.

Syndax Pharmaceuticals vs. Its Competitors

TG Therapeutics (NASDAQ:TGTX) and Syndax Pharmaceuticals (NASDAQ:SNDX) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, earnings, valuation, risk, institutional ownership, dividends, analyst recommendations and media sentiment.

58.6% of TG Therapeutics shares are held by institutional investors. 10.6% of TG Therapeutics shares are held by insiders. Comparatively, 4.1% of Syndax Pharmaceuticals shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

In the previous week, TG Therapeutics had 10 more articles in the media than Syndax Pharmaceuticals. MarketBeat recorded 18 mentions for TG Therapeutics and 8 mentions for Syndax Pharmaceuticals. TG Therapeutics' average media sentiment score of 0.48 beat Syndax Pharmaceuticals' score of 0.07 indicating that TG Therapeutics is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
TG Therapeutics
7 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
Syndax Pharmaceuticals
0 Very Positive mention(s)
1 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

TG Therapeutics presently has a consensus target price of $48.00, suggesting a potential upside of 35.55%. Syndax Pharmaceuticals has a consensus target price of $39.22, suggesting a potential upside of 161.31%. Given Syndax Pharmaceuticals' stronger consensus rating and higher possible upside, analysts clearly believe Syndax Pharmaceuticals is more favorable than TG Therapeutics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
TG Therapeutics
0 Sell rating(s)
1 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.80
Syndax Pharmaceuticals
0 Sell rating(s)
1 Hold rating(s)
8 Buy rating(s)
1 Strong Buy rating(s)
3.00

TG Therapeutics has a net margin of 13.31% compared to Syndax Pharmaceuticals' net margin of -428.48%. TG Therapeutics' return on equity of 26.05% beat Syndax Pharmaceuticals' return on equity.

Company Net Margins Return on Equity Return on Assets
TG Therapeutics13.31% 26.05% 9.58%
Syndax Pharmaceuticals -428.48%-130.47%-56.12%

TG Therapeutics has higher revenue and earnings than Syndax Pharmaceuticals. Syndax Pharmaceuticals is trading at a lower price-to-earnings ratio than TG Therapeutics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
TG Therapeutics$329M17.08$23.38M$0.3795.70
Syndax Pharmaceuticals$77.93M16.59-$318.76M-$3.89-3.86

TG Therapeutics has a beta of 1.88, meaning that its stock price is 88% more volatile than the S&P 500. Comparatively, Syndax Pharmaceuticals has a beta of 0.72, meaning that its stock price is 28% less volatile than the S&P 500.

Summary

TG Therapeutics beats Syndax Pharmaceuticals on 13 of the 17 factors compared between the two stocks.

Get Syndax Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for SNDX and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SNDX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SNDX vs. The Competition

MetricSyndax PharmaceuticalsMED IndustryMedical SectorNASDAQ Exchange
Market Cap$1.29B$3.11B$5.74B$10.35B
Dividend YieldN/A2.36%5.53%4.58%
P/E Ratio-3.8620.9076.3526.43
Price / Sales16.59254.49466.9890.96
Price / CashN/A46.3537.4661.85
Price / Book4.449.8313.186.39
Net Income-$318.76M-$52.73M$3.29B$271.22M
7 Day Performance1.76%4.85%2.50%2.79%
1 Month Performance-7.57%6.37%4.60%7.35%
1 Year Performance-17.89%19.15%73.81%29.74%

Syndax Pharmaceuticals Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SNDX
Syndax Pharmaceuticals
3.9165 of 5 stars
$15.01
+1.1%
$39.22
+161.3%
-17.2%$1.29B$77.93M-3.86110Positive News
TGTX
TG Therapeutics
4.3521 of 5 stars
$32.37
+1.0%
$48.00
+48.3%
+53.0%$5.14B$329M87.49290
PTCT
PTC Therapeutics
3.9012 of 5 stars
$61.13
+0.8%
$69.00
+12.9%
+64.8%$4.85B$806.78M8.751,410Positive News
KRYS
Krystal Biotech
4.9415 of 5 stars
$156.84
+1.8%
$209.00
+33.3%
-8.4%$4.54B$290.52M31.88210Positive News
ACLX
Arcellx
2.2775 of 5 stars
$78.71
+3.0%
$114.31
+45.2%
-7.9%$4.37B$107.94M-23.0180
ARWR
Arrowhead Pharmaceuticals
4.1371 of 5 stars
$30.60
+5.0%
$43.14
+41.0%
+62.5%$4.23B$572.98M-23.91400
ACAD
ACADIA Pharmaceuticals
4.3504 of 5 stars
$24.55
+1.4%
$29.65
+20.8%
+44.9%$4.14B$957.80M18.44510Trending News
Analyst Forecast
Options Volume
Gap Down
Trading Halted
MENS
Jyong Biotech
N/A$54.00
+0.5%
N/AN/A$4.11BN/A0.0031Gap Down
PCVX
Vaxcyte
1.9537 of 5 stars
$31.59
+2.3%
$106.25
+236.4%
-70.4%$4.10BN/A-7.69160
PTGX
Protagonist Therapeutics
1.6194 of 5 stars
$61.85
+4.4%
$68.08
+10.1%
+41.0%$3.85B$434.43M88.35120
ADMA
ADMA Biologics
3.2744 of 5 stars
$15.87
+2.0%
$27.67
+74.4%
-20.2%$3.79B$474.17M18.45530

Related Companies and Tools


This page (NASDAQ:SNDX) was last updated on 9/24/2025 by MarketBeat.com Staff
From Our Partners